Target 2035 – an update on private sector contributions

Ackloo S., Antolin AA., Bartolome JM., Beck H., Bullock A., Betz UAK., Böttcher J., Brown PJ., Chaturvedi M., Crisp A., Daniels D., Dreher J., Edfeldt K., Edwards AM., Egner U., Elkins J., Fischer C., Glendorf T., Goldberg S., Hartung IV., Hillisch A., Homan E., Knapp S., Köster M., Krämer O., Llaveria J., Lessel U., Lindemann S., Linderoth L., Matsui H., Michel M., Montel F., Mueller-Fahrnow A., Müller S., Owen DR., Saikatendu KS., Santhakumar V., Sanderson W., Scholten C., Schapira M., Sharma S., Shireman B., Sundström M., Todd MH., Tredup C., Venable J., Willson TM., Arrowsmith CH.

Target 2035, an international federation of biomedical scientists from the public and private sectors, is leveraging ‘open’ principles to develop a pharmacological tool for every human protein.

DOI

10.1039/d2md00441k

Type

Journal article

Journal

RSC Medicinal Chemistry

Publisher

Royal Society of Chemistry (RSC)

Publication Date

2023

Volume

14

Pages

1002 - 1011

Permalink Original publication